Search results
Lentigo (Liver Spots)
Health via Yahoo News· 5 days agoPsoralen plus ultraviolet A (PUVA) therapy combines psoralen (a chemical that makes the skin more sensitive to light) and UV light. Living With...
Derms Say These Are The Best Shampoos To Use If Your Scalp Is Dry And Itchy
Women's Health via AOL· 7 days agoThe best shampoos for dry scalp 2024, tested by experts and editors, are made with soothing,...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 1 day agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
Amgen Shares Jump After Teasing 'Encouraging' Weight Loss Data
US News & World Report· 9 hours agoInvestors late Thursday shrugged off a slight drop in the company's first-quarter adjusted profit and slightly-lower-than expected sales of drugs including arthritis treatment
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 5 hours agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoAbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript April 26, 2024 AbbVie Inc. beats earnings...
Amgen shares jump after teasing ‘encouraging’ weight loss data
WHTC 1450 Holland· 9 hours ago(Reuters) - U.S. drugmaker Amgen's shares jumped 13% to $316.26 premarket on Friday as the company...
Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 11 hours agoThe company received positive initial data from its Phase 2 psoriasis trial on hepatitis Delta, with significant virologic response rates observed. Vir Biotechnology Inc ( ...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks· 14 hours agoFree Report) reported a loss of 69 cents per share in the first quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 73 cents. In the year-ago quarter, Kymera reported a ...
Q1 2024 Vir Biotechnology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 9 hours agoCarey Hwang I'll begin by reminding you about the initial results from our Phase two psoriasis trial on hepatitis Delta, which was shared at a late-breaker presentation at ...
